Zobrazeno 1 - 10
of 9 126
pro vyhledávání: '"resistant hypertension"'
Autor:
Jaejin An, John J. Sim, Matt M. Zhou, Hui Zhou, Soon Kyu Choi, Jeffrey W. Brettler, Angeline L. Ong‐Su, Kristi Reynolds
Publikováno v:
The Journal of Clinical Hypertension, Vol 26, Iss 11, Pp 1318-1321 (2024)
ABSTRACT Sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) have demonstrated a blood pressure (BP) reduction benefit despite other indications for use. We evaluated BP changes and antihypertensive medication use pre‐ and post‐SGLT2i initiati
Externí odkaz:
https://doaj.org/article/5d48affa22d145f6bf244528bf7d3ae9
Publikováno v:
GAIMS Journal of Medical Sciences, Vol 5, Iss 1, Pp 38-45 (2024)
Background: Renal artery stenosis (RAS) is a significant cause of resistant hypertension, especially in patients presenting with comorbidities. Revascularization has been initially recommended to treat resistant hypertension due to RAS. However, rece
Externí odkaz:
https://doaj.org/article/f8eb8604bb5c469a805e1ae84f7307cc
Autor:
Ann‐Kathrin C. Schäfer, Manuel Wallbach, Charlotte Schroer, Luca‐Yves Lehnig, Stephan Lüders, Gerhard Hasenfuß, Rolf Wachter, Michael J. Koziolek
Publikováno v:
ESC Heart Failure, Vol 11, Iss 5, Pp 3360-3367 (2024)
Abstract Aims Arterial hypertension (aHTN) plays a fundamental role in the pathogenesis and prognosis of heart failure with preserved ejection fraction (HFpEF). The risk of heart failure increases with therapy‐resistant arterial hypertension (trHTN
Externí odkaz:
https://doaj.org/article/53f2d39717534c00a663015a6554e983
Publikováno v:
The Journal of Clinical Hypertension, Vol 26, Iss 9, Pp 1116-1120 (2024)
Abstract The authors report a case of primary aldosteronism (PA) with postoperative elevation of aldosterone treated effectively by finerenone. The patient was a hypertensive man with a 30‐year history of hypertension and sustained an acute myocard
Externí odkaz:
https://doaj.org/article/07018f3809254764940c5bba22d8894f
Autor:
H. N. Ranasinghe, P. N. Weeratunga, N. Fernando, P. Katulanda, S. Rajapakse, P. Galappatthy, S. M. Handunnetti, G. R. Constantine
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-8 (2024)
Abstract Objectives To perform a comparative analysis of the extended APPROPRIATE trial of measures of reactive nitrogen species and antioxidant capacity in patients having resistant hypertension with controlled hypertension and healthy controls. Res
Externí odkaz:
https://doaj.org/article/22d8702f11a448ad835a179aaea56a2b
Autor:
C. E. Durán, M. Bustamante, M. Barbosa, E. M. Useche, J. Triviño, L. Sandoval, P. A. Moncayo, A. M. Rivas, J. S. Zapata, J. D. Hernández Quintero, S. Meza, J. S. Bolaños, J. Schweineberg, L. Mesa, J. G. Posada
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Apparent resistant hypertension (aTRH) is a significant public health issue. Once low adherence to antihypertensive treatment has been ruled out and true resistant hypertension is diagnosed, aldosterone-direct-renin-ratio (ADRR) aids in the
Externí odkaz:
https://doaj.org/article/10c1cdd21fef4609b7f2f35c900d074a
Autor:
Marijn Marc Bult, Thomas Flint van deRee, Anna Maria Wind, Kai Morris Hurley, Marcel Allard van deRee
Publikováno v:
The Journal of Clinical Hypertension, Vol 26, Iss 8, Pp 977-985 (2024)
Abstract Left ventricular hypertrophy (LVH) is often used as an indicator to assess hypertension‐mediated organ damage (HMOD), alongside hypertensive retinopathy (HR) and nephropathy. Assessment of HMOD is crucial when making decisions about treatm
Externí odkaz:
https://doaj.org/article/415fd804b9da48c9a178481ec174c18a
Publikováno v:
Aksona, Vol 4, Iss 2, Pp 107-113 (2024)
Highlight: • CPAP therapy is a medical treatment for individuals suffering from OSA, a condition that is frequently linked to cardiovascular disease and resistant hypertension. • Five studies clearly showed that combining CPAP therapy with sta
Externí odkaz:
https://doaj.org/article/4f1e5a08fb284797adcd7bc944e9686d
Autor:
N. I. Gaponova, V. R. Abdrakhmanov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 3, Pp 340-348 (2024)
Activation of the sympathetic nervous system plays an important role in arterial hypertension (AH) development. Antihypertensive drugs of central action contribute to the elimination of sympathetic activation. The selective imidazoline receptor agoni
Externí odkaz:
https://doaj.org/article/188b242ad29f4153b25e1cabf3d3ebce
Autor:
David E. Kandzari, MD, Khoa N. Cao, MBBS, MPH, MS, Anne M. Ryschon, MA, Andrew S.P. Sharp, MBChB, MD, Jan B. Pietzsch, PhD
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions, Vol 3, Iss 10, Pp 102234- (2024)
Background: Catheter-based radiofrequency renal denervation (RF RDN) has recently been approved as an adjunctive treatment for hypertensive patients without adequate blood pressure control. This study assessed the cost-effectiveness of RF RDN in the
Externí odkaz:
https://doaj.org/article/4e9cfb6260764805ab1131e23e0397dd